British Columbia Investment Management’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-209,178
| Closed | -$20.8M | – | 847 |
|
|
2019
Q3 | $20.8M | Sell |
209,178
-40,673
| -16% | -$3.86M | 0.2% | 113 |
|
|
2019
Q2 | $23.1M | Buy |
249,851
+4,657
| +2% | +$442K | 0.2% | 114 |
|
|
2019
Q1 | $23.1M | Sell |
245,194
-97,107
| -28% | -$8.49M | 0.21% | 113 |
|
|
2018
Q4 | $21.9M | Buy |
342,301
+92,209
| +37% | +$6.81M | 0.2% | 119 |
|
|
2018
Q3 | $22.4M | Sell |
250,092
-79,861
| -24% | -$7.06M | 0.24% | 96 |
|
|
2018
Q2 | $26.2M | Sell |
329,953
-92,721
| -22% | -$7.7M | 0.23% | 103 |
|
|
2018
Q1 | $37.7M | Sell |
422,674
-145,723
| -26% | -$14M | 0.29% | 75 |
|
|
2017
Q4 | $59.3M | Buy |
568,397
+39,066
| +7% | +$4.41M | 0.42% | 52 |
|
|
2017
Q3 | $77.2M | Sell |
529,331
-661
| -0.1% | -$90K | 0.6% | 35 |
|
|
2017
Q2 | $68.8M | Sell |
529,992
-2,418
| -0.5% | -$296K | 0.55% | 40 |
|
|
2017
Q1 | $66.2M | Buy |
532,410
+49,975
| +10% | +$5.98M | 0.53% | 39 |
|
|
2016
Q4 | $55.8M | Buy |
482,435
+47,095
| +11% | +$5.24M | 0.49% | 46 |
|
|
2016
Q3 | $45.5M | Sell |
435,340
-62,706
| -13% | -$6.79M | 0.46% | 48 |
|
|
2016
Q2 | $49.1M | Buy |
498,046
+3,835
| +0.8% | +$397K | 0.43% | 47 |
|
|
2016
Q1 | $49.5M | Buy |
494,211
+23,267
| +5% | +$2.4M | 0.47% | 47 |
|
|
2015
Q4 | $56.4M | Sell |
470,944
-7,299
| -2% | -$844K | 0.54% | 43 |
|
|
2015
Q3 | $51.7M | Sell |
478,243
-4,879
| -1% | -$605K | 0.53% | 44 |
|
|
2015
Q2 | $55.9M | Buy |
483,122
+93,600
| +24% | +$10.7M | 0.53% | 41 |
|
|
2015
Q1 | $44.9M | Sell |
389,522
-30,068
| -7% | -$3.59M | 0.41% | 54 |
|
|
2014
Q4 | $46.9M | Sell |
419,590
-20,998
| -5% | -$2.21M | 0.39% | 58 |
|
|
2014
Q3 | $41.8M | Sell |
440,588
-35,316
| -7% | -$3.19M | 0.35% | 68 |
|
|
2014
Q2 | $40.9M | Buy |
475,904
+10,996
| +2% | +$836K | 0.33% | 75 |
|
|
2014
Q1 | $32.5M | Sell |
464,908
-38,328
| -8% | -$3.04M | 0.27% | 92 |
|
|
2013
Q4 | $42.5M | Sell |
503,236
-41,396
| -8% | -$3.28M | 0.34% | 74 |
|
|
2013
Q3 | $42M | Sell |
544,632
-42,522
| -7% | -$2.98M | 0.35% | 71 |
|
|
2013
Q2 | $34.3M | Buy |
+587,154
| New | +$35.3M | 0.28% | 88 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
British Columbia Investment Management's CELG Position: Q4 2019 in Review
British Columbia Investment Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 209,178 shares — an estimated $20.8M sold.
British Columbia Investment Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $77.2M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- British Columbia Investment Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- British Columbia Investment Management sold 209,178 Celgene Corp shares in Q4 2019, an estimated $20.8M.
- British Columbia Investment Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- British Columbia Investment Management's Celgene Corp position peaked at $77.2M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on British Columbia Investment Management's 13F filing for Q4 2019, filed 12 Feb 2020.